Loncar China BioPharma ETF Holdings
CHNA was created on 2018-08-14 by Loncar. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 4.03m in AUM and 68 holdings. CHNA tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry.
Last Updated: 9 hours ago
Last reported holdings - Loncar China BioPharma ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
None
|
DEPOSITS WITH BROKER FOR SHORT POSITIONS | $253074 |
|
None
|
POINT Biopharma Global Inc Ordinary Shares | $89083 |
|
None
|
Mirati Therapeutics Inc | $85636 |
|
None
|
Rain Oncology Inc | $63080 |
|
HCM
|
HUTCHMED (China) Ltd ADR | $58441 |
|
NUVL
|
Nuvalent Inc Class A | $54787 |
|
MRSN
|
Mersana Therapeutics Inc | $54414 |
|
ZYME
|
Zymeworks Inc Registered Shs | $53752 |
|
YMAB
|
Y-mAbs Therapeutics Inc | $53584 |
|
MGNX
|
Macrogenics Inc | $52800 |
|
None
|
Seagen Inc Ordinary Shares | $52582 |
|
ACLX
|
Arcellx Inc | $51262 |
|
None
|
EQRx Inc | $51058 |
|
LEGN
|
Legend Biotech Corp ADR | $50970 |
|
SMMT
|
Summit Therapeutics Inc Ordinary Shares | $50290 |
|
REGN
|
Regeneron Pharmaceuticals Inc | $50125 |
|
EXAI
|
Exscientia PLC ADR | $49944 |
|
VOR
|
Vor Biopharma Inc Ordinary Shares | $49306 |
|
EXEL
|
Exelixis Inc | $49207 |
|
BMY
|
Bristol-Myers Squibb Co | $48612 |
|
MRK
|
Merck & Co Inc | $48563 |
|
TYRA
|
Tyra Biosciences Inc | $48557 |
|
CMPX
|
Compass Therapeutics Inc Ordinary Shares | $47255 |
|
TSVT
|
2seventy bio Inc Ordinary Shares | $47196 |
|
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | $46624 |
|
BPMC
|
Blueprint Medicines Corp | $46405 |
|
FATE
|
Fate Therapeutics Inc | $46214 |
|
None
|
Ambrx Biopharma Inc | $45884 |
|
None
|
Immunogen Inc | $45761 |
|
NUVB
|
Nuvation Bio Inc Ordinary Shares - Class A | $45752 |
|
IMCR
|
Immunocore Holdings PLC ADR | $45521 |
|
AURA
|
Aura Biosciences Inc | $45377 |
|
AUTL
|
Autolus Therapeutics PLC ADR | $45343 |
|
GNLX
|
Genelux Corp | $45275 |
|
TNGX
|
Tango Therapeutics Inc | $45044 |
|
RVMD
|
Revolution Medicines Inc Ordinary Shares | $44780 |
|
XNCR
|
Xencor Inc | $44693 |
|
ACET
|
Adicet Bio Inc Ordinary Shares | $44592 |
|
CGEM
|
Cullinan Oncology Inc Ordinary Shares | $44558 |
|
KPTI
|
Karyopharm Therapeutics Inc | $44533 |
|
IDYA
|
IDEAYA Biosciences Inc | $44080 |
|
ERAS
|
Erasca Inc | $43741 |
|
KURA
|
Kura Oncology Inc | $42508 |
|
SWTX
|
SpringWorks Therapeutics Inc Ordinary Shares | $42421 |
|
MRUS
|
Merus NV | $42346 |
|
REPL
|
Replimune Group Inc | $42175 |
|
GERN
|
Geron Corp | $41864 |
|
BCYC
|
Bicycle Therapeutics PLC ADR | $41756 |
|
MOR2
|
MorphoSys AG ADR | $41669 |
|
STRO
|
Sutro Biopharma Inc | $41473 |
|
DNA4EUR
|
Ginkgo Bioworks Holdings Inc | $41352 |
|
None
|
Theseus Pharmaceuticals Inc | $40985 |
|
BNTX
|
BioNTech SE ADR | $40910 |
|
ELVN
|
Enliven Therapeutics Inc | $39936 |
|
GMAB
|
Genmab A/S ADR | $39926 |
|
RCUS
|
Arcus Biosciences Inc | $39833 |
|
IPHA
|
Innate Pharma SA ADR | $39615 |
|
ALLO
|
Allogene Therapeutics Inc | $39204 |
|
ZNTL
|
Zentalis Pharmaceuticals Inc Ordinary Shares | $38969 |
|
None
|
Deciphera Pharmaceuticals Inc | $38675 |
|
PRLD
|
Prelude Therapeutics Inc Ordinary Shares | $38207 |
|
None
|
Inhibrx Inc Ordinary Shares | $37997 |
|
IMRX
|
Immuneering Corp Class A | $37132 |
|
None
|
NGM Biopharmaceuticals Inc | $36772 |
|
RLAY
|
Relay Therapeutics Inc Ordinary Shares | $36727 |
|
ITOS
|
ITeos Therapeutics Inc Ordinary Shares | $36721 |
|
IBRX
|
ImmunityBio Inc Ordinary Shares | $36715 |
|
IMTX
|
Immatics NV Ordinary Shares | $36362 |
|
BMEA
|
Biomea Fusion Inc | $36313 |
|
PGEN
|
Precigen Inc | $36164 |
|
RXRX
|
Recursion Pharmaceuticals Inc Class A | $35414 |
|
DAWN
|
Day One Biopharmaceuticals Inc | $35351 |
|
JANX
|
Janux Therapeutics Inc Ordinary Shares | $34762 |
|
AGEN
|
Agenus Inc | $34699 |
|
CRBU
|
Caribou Biosciences Inc Ordinary Shares | $33919 |
|
SDGR
|
Schrodinger Inc Ordinary Shares | $33827 |
|
SNDX
|
Syndax Pharmaceuticals Inc | $33701 |
|
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | $32416 |
|
IOVA
|
Iovance Biotherapeutics Inc | $32121 |
|
ARVN
|
Arvinas Inc | $30891 |
|
IGMS
|
IGM Biosciences Inc Ordinary Shares | $30115 |
|
RAPT
|
RAPT Therapeutics Inc Ordinary Shares | $29746 |
|
NRIX
|
Nurix Therapeutics Inc Ordinary Shares | $27428 |
|
ACRV
|
Acrivon Therapeutics Inc | $26692 |
|
GLUE
|
Monte Rosa Therapeutics Inc | $23175 |
|
FHTX
|
Foghorn Therapeutics Inc Ordinary Shares | $22958 |
|
APLM
|
Apollomics Inc Ordinary Shares - Class A | $22507 |
|
RPTX
|
Repare Therapeutics Inc Ordinary Shares | $21403 |
|
None
|
CHINESE YUAN | $967 |
|
None
|
HONG KONG DOLLAR | $-754 |
|
None
|
US DOLLARS | $-253295 |
Recent Changes - Loncar China BioPharma ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2023-10-19 |
9926.HK
|
Akeso Inc Ordinary Shares | -15,000 |
| 2023-10-19 |
RPTX
|
Repare Therapeutics Inc Ordinary Shares | 4,926 |
| 2023-10-19 |
NUVB
|
Nuvation Bio Inc Ordinary Shares - Class A | 39,104 |
| 2023-10-19 |
DAWN
|
Day One Biopharmaceuticals Inc | 3,652 |
| 2023-10-19 |
MRK
|
Merck & Co Inc | 473 |
| 2023-10-19 |
YMAB
|
Y-mAbs Therapeutics Inc | 10,187 |
| 2023-10-19 |
IMCR
|
Immunocore Holdings PLC ADR | 963 |
| 2023-10-19 |
2126.HK
|
JW (Cayman) Therapeutics Co Ltd Ordinary Shares | -96,000 |
| 2023-10-19 |
1477.HK
|
Ocumension Therapeutics Ordinary Shares | -65,000 |
| 2023-10-19 |
SGEN
|
Seagen Inc Ordinary Shares | 244 |
| 2023-10-19 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | 30,080 |
| 2023-10-19 |
ACRV
|
Acrivon Therapeutics Inc | 4,818 |
| 2023-10-19 |
FATE
|
Fate Therapeutics Inc | 23,107 |
| 2023-10-19 |
6606.HK
|
New Horizon Health Ltd Ordinary Shares | -21,500 |
| 2023-10-19 |
6600.HK
|
SciClone Pharmaceuticals (Holdings) Ltd | -51,500 |
| 2023-10-19 |
BNR
|
Burning Rock Biotech Ltd ADR | -20,765 |
| 2023-10-19 |
9969.HK
|
InnoCare Pharma Ltd | -51,000 |
| 2023-10-19 |
6996.HK
|
Antengene Corp Ltd | -99,000 |
| 2023-10-19 |
ZYME
|
Zymeworks Inc Registered Shs | 7,476 |
| 2023-10-19 |
BMY
|
Bristol-Myers Squibb Co | 861 |
| 2023-10-19 |
MRSN
|
Mersana Therapeutics Inc | 35,799 |
| 2023-10-19 |
IMTX
|
Immatics NV Ordinary Shares | 4,170 |
| 2023-10-19 |
REGN
|
Regeneron Pharmaceuticals Inc | 62 |
| 2023-10-19 |
PRLD
|
Prelude Therapeutics Inc Ordinary Shares | 15,986 |
| 2023-10-19 |
ALLO
|
Allogene Therapeutics Inc | 13,068 |
| 2023-10-19 |
IMGN
|
Immunogen Inc | 3,234 |
| 2023-10-19 |
2552.HK
|
Hua Medicine | -104,500 |
| 2023-10-19 |
2005.HK
|
SSY Group Ltd | -151,000 |
| 2023-10-19 |
IBRX
|
ImmunityBio Inc Ordinary Shares | 28,242 |
| 2023-10-19 |
BCYC
|
Bicycle Therapeutics PLC ADR | 2,439 |
| 2023-10-19 |
6826.HK
|
Shanghai Haohai Biological Technology Co Ltd Shs -H- Unitary 144A/Reg S | -18,200 |
| 2023-10-19 |
3759.HK
|
Pharmaron Beijing Co Ltd Ordinary Shares - Class H | -27,450 |
| 2023-10-19 |
LIAN
|
LianBio ADR | -27,778 |
| 2023-10-19 |
2162.HK
|
Keymed Biosciences Inc | -9,500 |
| 2023-10-19 |
2616.HK
|
CStone Pharmaceuticals | -106,500 |
| 2023-10-19 |
6127.HK
|
Joinn Laboratories (China) Co Ltd Class H | -25,536 |
| 2023-10-19 |
ZLAB
|
Zai Lab Ltd ADR Repr 1 Shs | -2,344 |
| 2023-10-19 |
1873.HK
|
Viva Biotech Holdings | -276,000 |
| 2023-10-19 |
9939.HK
|
Kintor Pharmaceutical Ltd Ordinary Shares | -48,000 |
| 2023-10-19 |
IMAB
|
I-MAB ADR | -12,898 |
| 2023-10-19 |
RAIN
|
Rain Oncology Inc | 61,843 |
| 2023-10-19 |
MRUS
|
Merus NV | 2,086 |
| 2023-10-19 |
PNT
|
POINT Biopharma Global Inc Ordinary Shares | 6,879 |
| 2023-10-19 |
NRIX
|
Nurix Therapeutics Inc Ordinary Shares | 5,738 |
| 2023-10-19 |
TYRA
|
Tyra Biosciences Inc | 3,456 |
| 2023-10-19 |
SWTX
|
SpringWorks Therapeutics Inc Ordinary Shares | 1,930 |
| 2023-10-19 |
PGEN
|
Precigen Inc | 34,117 |
| 2023-10-19 |
867.HK
|
China Medical System Holdings Ltd | -52,000 |
| 2023-10-19 |
IPHA
|
Innate Pharma SA ADR | 17,002 |
| 2023-10-19 |
ACLX
|
Arcellx Inc | 1,538 |
| 2023-10-19 |
ARVN
|
Arvinas Inc | 2,083 |
| 2023-10-19 |
EQRX
|
EQRx Inc | 22,394 |
| 2023-10-19 |
APLM
|
Apollomics Inc Ordinary Shares - Class A | 12,935 |
| 2023-10-19 |
1672.HK
|
Ascletis Pharma Inc Ordinary Shares | -121,000 |
| 2023-10-19 |
SNDX
|
Syndax Pharmaceuticals Inc | 2,928 |
| 2023-10-19 |
1177.HK
|
Sino Biopharmaceutical Ltd | -218,500 |
| 2023-10-19 |
2315.HK
|
Biocytogen Pharmaceuticals (Beijing) Co Ltd Class H | -28,000 |
| 2023-10-19 |
GERN
|
Geron Corp | 23,002 |
| 2023-10-19 |
2607.HK
|
Shanghai Pharmaceuticals Holding Co Ltd Class H | -51,700 |
| 2023-10-19 |
9995.HK
|
RemeGen Co Ltd Class H | -11,000 |
| 2023-10-19 |
9966.HK
|
Alphamab Oncology Ordinary Shares | -47,000 |
| 2023-10-19 |
EXAI
|
Exscientia PLC ADR | 9,890 |
| 2023-10-19 |
GMAB
|
Genmab A/S ADR | 1,338 |
| 2023-10-19 |
RXRX
|
Recursion Pharmaceuticals Inc Class A | 5,932 |
| 2023-10-19 |
1801.HK
|
Innovent Biologics Inc | -16,500 |
| 2023-10-19 |
FHTX
|
Foghorn Therapeutics Inc Ordinary Shares | 7,809 |
| 2023-10-19 |
1548.HK
|
Genscript Biotech Corp Class H | -28,000 |
| 2023-10-19 |
IMRX
|
Immuneering Corp Class A | 6,315 |
| 2023-10-19 |
GU5.DE
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class H | -31,000 |
| 2023-10-19 |
1530.HK
|
3SBio Inc Shs Unitary 144A/Reg S | -85,000 |
| 2023-10-19 |
AGEN
|
Agenus Inc | 38,805 |
| 2023-10-19 |
1877.HK
|
Shanghai Junshi Biosciences Co Ltd Class H | -19,800 |
| 2023-10-19 |
1558.HK
|
Yichang HEC ChangJiang Pharmaceutical Co Ltd Shs -H- Unitary 144A/Reg S | -63,800 |
| 2023-10-19 |
6622.HK
|
Zhaoke Ophthalmology Ltd | -90,000 |
| 2023-10-19 |
460.HK
|
Sihuan Pharmaceutical Holdings Group Ltd | -696,000 |
| 2023-10-19 |
2359.HK
|
Wuxi AppTec Co Ltd | -10,257 |
| 2023-10-19 |
3347.HK
|
Hangzhou Tigermed Consulting Co Ltd Class H | -9,700 |
| 2023-10-19 |
2096.HK
|
Simcere Pharmaceutical Group Ltd Ordinary Shares | -64,000 |
| 2023-10-19 |
RAPT
|
RAPT Therapeutics Inc Ordinary Shares | 2,607 |
| 2023-10-19 |
SDGR
|
Schrodinger Inc Ordinary Shares | 1,539 |
| 2023-10-19 |
512.HK
|
Grand Pharmaceutical Group Ltd | -146,000 |
| 2023-10-19 |
2137.HK
|
Brii Biosciences Ltd Ordinary Shares | -62,000 |
| 2023-10-19 |
GLUE
|
Monte Rosa Therapeutics Inc | 8,458 |
| 2023-10-19 |
1244.HK
|
3D Medicines Inc | -10,000 |
| 2023-10-19 |
NUVL
|
Nuvalent Inc Class A | 1,073 |
| 2023-10-19 |
GNLX
|
Genelux Corp | 2,248 |
| 2023-10-19 |
1093.HK
|
CSPC Pharmaceutical Group Ltd | -110,880 |
| 2023-10-19 |
6185.HK
|
CanSino Biologics Inc Class H | -10,400 |
| 2023-10-19 |
2142.HK
|
HBM Holdings Ltd Ordinary Shares | -156,000 |
| 2023-10-19 |
BGNE
|
BeiGene Ltd ADR | -507 |
| 2023-10-19 |
TSVT
|
2seventy bio Inc Ordinary Shares | 12,552 |
| 2023-10-19 |
6660.HK
|
AIM Vaccine Co Ltd Class H | -29,400 |
| 2023-10-19 |
1167.HK
|
Jacobio Pharmaceuticals Group Co Ltd Ordinary Shares | -73,200 |
| 2023-10-19 |
ITOS
|
ITeos Therapeutics Inc Ordinary Shares | 4,126 |
| 2023-10-19 |
JANX
|
Janux Therapeutics Inc Ordinary Shares | 5,150 |
| 2023-10-19 |
REPL
|
Replimune Group Inc | 2,842 |
| 2023-10-19 |
MRTX
|
Mirati Therapeutics Inc | 1,538 |
| 2023-10-19 |
IOVA
|
Iovance Biotherapeutics Inc | 9,646 |
| 2023-10-19 |
KPTI
|
Karyopharm Therapeutics Inc | 42,012 |
| 2023-10-19 |
AUTL
|
Autolus Therapeutics PLC ADR | 17,712 |
| 2023-10-19 |
XNCR
|
Xencor Inc | 2,457 |
| 2023-10-19 |
VOR
|
Vor Biopharma Inc Ordinary Shares | 21,817 |
| 2023-10-19 |
AMAM
|
Ambrx Biopharma Inc | 5,443 |
| 2023-10-19 |
BMEA
|
Biomea Fusion Inc | 3,353 |
| 2023-10-19 |
CGEM
|
Cullinan Oncology Inc Ordinary Shares | 5,104 |
| 2023-10-19 |
1513.HK
|
Livzon Pharmaceutical Group Inc Class H | -25,870 |
| 2023-10-19 |
DNA
|
Ginkgo Bioworks Holdings Inc | 26,339 |
| 2023-10-19 |
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | 2,668 |
| 2023-10-19 |
ERAS
|
Erasca Inc | 19,703 |
| 2023-10-19 |
IGMS
|
IGM Biosciences Inc Ordinary Shares | 6,907 |
| 2023-10-19 |
DCPH
|
Deciphera Pharmaceuticals Inc | 3,788 |
| 2023-10-19 |
EXEL
|
Exelixis Inc | 2,331 |
| 2023-10-19 |
MOR
|
MorphoSys AG ADR | 6,323 |
| 2023-10-19 |
1952.HK
|
Everest Medicines Ltd Ordinary Shares | -32,500 |
| 2023-10-19 |
STRO
|
Sutro Biopharma Inc | 13,001 |
| 2023-10-19 |
CRBU
|
Caribou Biosciences Inc Ordinary Shares | 8,675 |
| 2023-10-19 |
THRX
|
Theseus Pharmaceuticals Inc | 17,590 |
| 2023-10-19 |
MGNX
|
Macrogenics Inc | 10,909 |
| 2023-10-19 |
KURA
|
Kura Oncology Inc | 5,140 |
| 2023-10-19 |
1099.HK
|
Sinopharm Group Co Ltd | -36,700 |
| 2023-10-19 |
BNTX
|
BioNTech SE ADR | 450 |
| 2023-10-19 |
RCUS
|
Arcus Biosciences Inc | 2,471 |
| 2023-10-19 |
ACET
|
Adicet Bio Inc Ordinary Shares | 29,728 |
| 2023-10-19 |
2186.HK
|
Luye Pharma Group Ltd | -173,000 |
| 2023-10-19 |
3692.HK
|
Hansoh Pharmaceutical Group Co Ltd | -64,000 |
| 2023-10-19 |
RVMD
|
Revolution Medicines Inc Ordinary Shares | 1,601 |
| 2023-10-19 |
AURA
|
Aura Biosciences Inc | 5,402 |
| 2023-10-19 |
BPMC
|
Blueprint Medicines Corp | 1,004 |
| 2023-10-19 |
SMMT
|
Summit Therapeutics Inc Ordinary Shares | 27,184 |
| 2023-10-19 |
NGM
|
NGM Biopharmaceuticals Inc | 38,805 |
| 2023-10-19 |
6821.HK
|
Asymchem Laboratories Tianjin Co Ltd Class H | -5,940 |
| 2023-10-19 |
IDYA
|
IDEAYA Biosciences Inc | 1,743 |
| 2023-10-19 |
ZNTL
|
Zentalis Pharmaceuticals Inc Ordinary Shares | 2,171 |
| 2023-10-19 |
RLAY
|
Relay Therapeutics Inc Ordinary Shares | 5,425 |
| 2023-10-19 |
2269.HK
|
WuXi Biologics (Cayman) Inc | -15,000 |
| 2023-10-19 |
2196.HK
|
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H | -40,500 |
| 2023-10-19 |
INBX
|
Inhibrx Inc Ordinary Shares | 2,431 |
| 2023-10-19 |
ELVN
|
Enliven Therapeutics Inc | 3,157 |
| 2023-10-19 |
CMPX
|
Compass Therapeutics Inc Ordinary Shares | 23,866 |
| 2023-10-19 |
TNGX
|
Tango Therapeutics Inc | 5,974 |
| 2023-10-19 |
3320.HK
|
China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S | -116,000 |
| 2023-06-27 |
FGXXX
|
First American Government Obligs X | 3,006 |
| 2023-06-07 |
FGXXX
|
First American Government Obligs X | -596 |
| 2023-05-15 |
FGXXX
|
First American Government Obligs X | 593 |
| 2023-03-08 |
FGXXX
|
First American Government Obligs X | -3,475 |
| 2022-12-01 |
6826.HK
|
Shanghai Haohai Biological Technology Co Ltd Shs -H- Unitary 144A/Reg S | 23,600 |
| 2022-11-30 |
6826.HK
|
Shanghai Haohai Biological Technology Co Ltd Shs -H- Unitary 144A/Reg S | -23,600 |
| 2022-10-10 |
6821.HK
|
Asymchem Laboratories Tianjin Co Ltd Class H | 7,040 |
| 2022-10-07 |
6821.HK
|
Asymchem Laboratories Tianjin Co Ltd Class H | -7,040 |
| 2022-08-09 |
2616.HK
|
CStone Pharmaceuticals | 27,500 |
| 2022-08-09 |
2126.HK
|
JW (Cayman) Therapeutics Co Ltd Ordinary Shares | 9,000 |
| 2022-08-09 |
1873.HK
|
Viva Biotech Holdings | 78,000 |
| 2022-08-09 |
2142.HK
|
HBM Holdings Ltd Ordinary Shares | 36,000 |
| 2022-08-09 |
2005.HK
|
SSY Group Ltd | -80,000 |
| 2022-08-09 |
1513.HK
|
Livzon Pharmaceutical Group Inc Class H | -1,500 |
| 2022-08-09 |
3692.HK
|
Hansoh Pharmaceutical Group Co Ltd | -7,500 |
| 2022-08-09 |
1952.HK
|
Everest Medicines Ltd Ordinary Shares | 9,000 |
| 2022-08-09 |
LIAN
|
LianBio ADR | 8,703 |
| 2022-08-09 |
LEGN
|
Legend Biotech Corp ADR | -968 |
| 2022-08-09 |
6127.HK
|
Joinn Laboratories (China) Co Ltd Class H | -7,000 |
| 2022-08-09 |
1672.HK
|
Ascletis Pharma Inc Ordinary Shares | 18,000 |
| 2022-08-09 |
1167.HK
|
Jacobio Pharmaceuticals Group Co Ltd Ordinary Shares | 119,100 |
| 2022-08-09 |
1177.HK
|
Sino Biopharmaceutical Ltd | 10,000 |
| 2022-08-09 |
1548.HK
|
Genscript Biotech Corp Class H | -10,000 |
| 2022-08-09 |
GU5.DE
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class H | -10,000 |
| 2022-08-09 |
2607.HK
|
Shanghai Pharmaceuticals Holding Co Ltd Class H | 6,700 |
| 2022-08-09 |
6826.HK
|
Shanghai Haohai Biological Technology Co Ltd Shs -H- Unitary 144A/Reg S | 2,900 |
| 2022-08-09 |
775.HK
|
CK Life Sciences International Holdings Inc | 692,000 |
| 2022-08-09 |
GTH
|
Genetron Holdings Ltd ADR | -21,947 |
| 2022-08-09 |
GRCL
|
Gracell Biotechnologies Inc ADR | -3,280 |
| 2022-08-09 |
6996.HK
|
Antengene Corp Ltd | -101,000 |
| 2022-08-09 |
2197.HK
|
Clover Biopharmaceuticals Ltd | 97,000 |
| 2022-08-09 |
CNTB
|
Connect Biopharma Holdings Ltd ADR | -18,062 |
| 2022-08-09 |
PRE
|
Prenetics Global Ltd Class A | 16,218 |
| 2022-08-09 |
9939.HK
|
Kintor Pharmaceutical Ltd Ordinary Shares | -25,000 |
| 2022-08-09 |
9966.HK
|
Alphamab Oncology Ordinary Shares | -4,000 |
| 2022-08-09 |
IMAB
|
I-MAB ADR | 2,262 |
| 2022-08-09 |
BNR
|
Burning Rock Biotech Ltd ADR | 10,735 |
| 2022-08-09 |
1099.HK
|
Sinopharm Group Co Ltd | -8,400 |
| 2022-08-09 |
1477.HK
|
Ocumension Therapeutics Ordinary Shares | 64,500 |
| 2022-08-09 |
6978.HK
|
Immunotech Biopharm Ltd Ordinary Shares | 25,000 |
| 2022-08-09 |
1558.HK
|
Yichang HEC ChangJiang Pharmaceutical Co Ltd Shs -H- Unitary 144A/Reg S | 18,200 |
| 2022-08-09 |
1093.HK
|
CSPC Pharmaceutical Group Ltd | -6,000 |
| 2022-08-09 |
2196.HK
|
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H | -1,000 |
| 2022-08-09 |
6606.HK
|
New Horizon Health Ltd Ordinary Shares | -4,000 |
| 2022-08-09 |
ZLAB
|
Zai Lab Ltd ADR Repr 1 Shs | 286 |
| 2022-08-09 |
2269.HK
|
WuXi Biologics (Cayman) Inc | -6,500 |
| 2022-08-09 |
2359.HK
|
Wuxi AppTec Co Ltd | -2,000 |
| 2022-08-09 |
3759.HK
|
Pharmaron Beijing Co Ltd Ordinary Shares - Class H | -4,900 |
| 2022-08-09 |
3347.HK
|
Hangzhou Tigermed Consulting Co Ltd Class H | -3,700 |
| 2022-08-09 |
1801.HK
|
Innovent Biologics Inc | -5,000 |
| 2022-08-09 |
1530.HK
|
3SBio Inc Shs Unitary 144A/Reg S | 10,500 |
| 2022-08-09 |
1877.HK
|
Shanghai Junshi Biosciences Co Ltd Class H | 4,200 |
| 2022-08-09 |
460.HK
|
Sihuan Pharmaceutical Holdings Group Ltd | 34,000 |
| 2022-08-09 |
512.HK
|
Grand Pharmaceutical Group Ltd | 21,500 |
| 2022-08-09 |
2186.HK
|
Luye Pharma Group Ltd | 72,000 |
| 2022-08-09 |
HCM
|
HUTCHMED (China) Ltd ADR | 3,159 |
| 2022-08-09 |
2096.HK
|
Simcere Pharmaceutical Group Ltd Ordinary Shares | -24,000 |
| 2022-08-09 |
6185.HK
|
CanSino Biologics Inc Class H | 5,200 |
| 2022-08-09 |
867.HK
|
China Medical System Holdings Ltd | -4,000 |